Capsida Uncloaks With $140M In Funding
socalTECH
APRIL 29, 2021
The startup is backed by $50M in a Series A funding from Versant Ventures and Westlake Village BioPartners, and an additional $90M multi-year strategic collaboration and option agreement with AbbVie. The company said its technology was originally developed based on research in the laboratory of Viviana Gradinaru, Ph.D.,
Let's personalize your content